Identifying Biomarkers in Pancreatic Juice for Pancreatic Cancer
Author Information
Author(s): Tian Mei, Cui Ya-Zhou, Song Guan-Hua, Zong Mei-Juan, Zhou Xiao-Yan, Chen Yu, Han Jin-Xiang
Primary Institution: Shandong Academy of Medical Sciences
Hypothesis
Can proteomic analysis of pancreatic juice identify specific biomarkers for pancreatic ductal adenocarcinoma (PDAC)?
Conclusion
MMP-9, DJ-1, and A1BG are elevated in pancreatic juice from PDAC patients, suggesting their potential use in diagnosis and screening.
Supporting Evidence
- 14 proteins were up-regulated and 10 proteins were down-regulated in cancerous pancreatic juice compared to cancer-free controls.
- MMP-9, DJ-1, and A1BG were confirmed to be elevated in pancreatic cancer tissues.
- Serum MMP-9 levels were significantly higher in PDAC patients compared to chronic pancreatitis and healthy controls.
Takeaway
Doctors are looking for special proteins in the juice from the pancreas to help find pancreatic cancer earlier.
Methodology
The study used difference gel electrophoresis (DIGE) and tandem mass spectrometry to analyze pancreatic juice from PDAC patients and cancer-free controls.
Limitations
The study had a limited number of cancer-free pancreatic juice specimens.
Participant Demographics
9 PDAC patients and 9 cancer-free controls, with a mix of genders and ages ranging from 12 to 73.
Statistical Information
P-Value
0.009 for PDAC vs chronic pancreatitis; 0.027 for PDAC vs healthy controls
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website